Analyst Predicts Black Box Warning For Byetta

Law360, New York (September 3, 2008, 12:00 AM EDT) -- Amid cases of severe pancreatitis in patients taking the diabetes drug Byetta — and two deaths linked to the injectable medication — a financial analyst said Tuesday that the U.S. Food and Drug Administration might soon require a top-level warning label.

"We think Byetta could get a black box pancreatitis warning," analyst Adam Cutler of Canaccord Adams Inc. said in a research note, which also stated that “the FDA suspects Byetta causes pancreatitis.”

Amylin Pharmaceuticals had no immediate comment on the matter Wednesday.

In a statement...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.